Credit: CC0 Public Domain

Yale doctors have developed a technique to predict whether cancer patients receiving a common chemotherapy drug are likely to experience heart failure as a result.

The chemotherapy drug, called doxorubicin, is used to treat a number of cancers, including breast and bladder cancers, lymphoma, and Kaposi’s sarcoma. It is a powerful medication, researchers say, and in some cases it severely damages the .

But a new, non-invasive procedure may be able to help screen for early signs of impending in taking doxorubicin. A study based on an animal model experiment